Tick-borne testing kit with Jivora and Tasso branding on a light blue background
Tick-borne testing kit with Jivora and Tasso branding on a light blue background

Jivora Rickettsial Immune Response Panel™ (Practitioner)

Regular price $404.89
Sale price $404.89 Regular price $1,687.83 Bundle Price
Unit price
  • SKU:
    JPPSI004
Ask a question

Ask a Question

* Required fields

Size guide Share

About Jivora Rickettsial Immune Response Panel™

A high-specificity serological evaluation kit designed exclusively for the detection of antibodies to spotted fever and typhus-group Rickettsia.

 

This bundle includes:

  • JP019 - Jivora Bartonella IgG-antibodies (hens.+quint.)™
  • JP021 - Jivora Bartonella IgM-antibodies (hens.+quint.)™
  • JP064 - Jivora Babesia microti EliSpot™

Who It’s For

Infectious disease specialists and practitioners treating acute or lingering malaise, vasculitis, headaches, or atypical rashes following known or suspected vector interaction.

 

What It Measures

IgG and IgM antibody titers for Rickettsia rickettsii (Rocky Mountain Spotted Fever) and related rickettsial organisms.


How it works (3 steps):

  • Order
  • Collect at home & return ship 
  • Get results and review next steps


More About Your Jivora Rickettsial Immune Response Panel™


Convenient Access to Wellness Insights

You can order your testing kit directly through Jivora Health, an authorized ArminLabs partner. Our streamlined online process respects your privacy and security, allowing you to take a proactive role in monitoring your immune health without the need for a prior office visit.


Simple, Needle-Free Collection at Home

Each kit features the FDA-cleared Tasso+ device, designed for easy and virtually painless blood collection from the upper arm. This innovative technology allows you to collect a high-quality sample without traditional needles. If you prefer, a standard clinical blood draw option is also available. Both methods are validated for sample stability and laboratory accuracy.


Informational Results for Better Conversations

Your report provides a detailed look at how your immune system reacts to specific tick-borne antigens. These findings are educational in nature and intended to help you have more informed discussions with your healthcare provider. Please note that these results are not a medical diagnosis and should not be used as a standalone basis for a treatment plan.


Medications and Testing

While most common medications do not impact the results, certain intensive therapies - such as strong immunosuppressants, chemotherapy, or interferon-gamma therapy - may affect your immune system’s natural reactivity. We recommend consulting your clinician before sample collection if you are currently undergoing these treatments.


Fast, Secure, and Supported

Once your sample is received by the laboratory, your secure digital report is typically available within 7 to 10 business days. To help you navigate your findings, Jivora Health provides access to a complimentary educational review to explain the data markers in your report.


Comprehensive Immune Screening

Traditional screenings often focus on a single strain of Borrelia. The ArminLabs approach provides a broader perspective by screening for reactivity to Borrelia burgdorferi, Borrelia afzelii, and Borrelia garinii. By including persistent-form (round-body) antigens, this test offers a more comprehensive view of your immune profile, reducing the limitations found in narrower testing methods.


Understanding Your Immune Markers

  • IgM Reactivity: Typically associated with a more recent or active immune response.

  • IgG Reactivity: Generally indicates an immune memory or long-term reactivity. ArminLabs calibrates these markers to provide you and your healthcare professional with a clear map of your immune system’s history and current status.


The Science of Antigen Diversity

Borrelia bacteria are known for their ability to shift forms, including "round-body" or pleomorphic states. Because these different forms can trigger different immune responses, our testing includes specific antigens for both active and persistent forms. This multi-antigen approach ensures a more thorough assessment of immune reactivity that standard screenings might overlook.


Regulatory Status: The Tasso+ collection device is FDA-cleared. The laboratory tests provided by ArminLabs are Laboratory Developed Tests (LDTs). These tests have not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary for LDTs when performed by a CLIA-certified laboratory.

Educational Use: These results are for informational purposes only. They are not intended to diagnose, treat, cure, or prevent any disease. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

 

*This test was developed and its performance characteristics determined by ArminLabs. It has not been cleared or approved by the U.S. Food and Drug Administration. This test is intended for informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Technical Information
key fact
Early or lingering rickettsial presentations can be identified through distinct titer shifts even in the absence of a classic rash.
material
1 x rigid stylized storage box container, 1 x clear security protective transport container, 1 x primary blood sample preservation tube, 2 x customized high-precision finger lancets, 1 x sterile gauze pad, 2 x sterile skin preparation swabs, 1 x adhesive dressing strip, 1 x individual identification barcode tracking label, 1 x patient symptom logging manifest sheet, and 1 x pre-paid laboratory return shipping envelope.
further information on the test
Uses reference-standard immunofluorescent assay technology to verify acute or past exposure via distinct immunoglobulin profiling phases.
further information on the pathogen
Rickettsia are obligate intracellular bacteria that target endothelial cells lining blood vessels, potentially leading to systemic vascular complications.

Important:These test results are for informational and educational purposes only. They provide immune response markers and are not intended to diagnose, treat, cure, or prevent any disease. This test should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making any health-related decisions based on test results.